Fidelity Investments’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$88.6K Buy
25,912
+1,413
+6% +$4.39K ﹤0.01% 4030
2026
Q1
$55.9K Buy
24,499
+12,129
+98% +$27.9K ﹤0.01% 4082
2025
Q4
$34.6K Buy
12,370
+8,029
+185% +$28.7K ﹤0.01% 4258
2025
Q3
$20.8K Sell
4,341
-32,985
-88% -$210K ﹤0.01% 4342
2025
Q2
$340K Sell
37,326
-2,681,428
-99% -$19.8M ﹤0.01% 3114
2025
Q1
$24.6M Sell
2,718,754
-8,846,631
-76% -$93.4M ﹤0.01% 1614
2024
Q4
$151M Buy
11,565,385
+761
+0% +$10.1K 0.01% 942
2024
Q3
$181M Buy
11,564,624
+90,862
+0.8% +$1.38M 0.01% 856
2024
Q2
$155M Sell
11,473,762
-15,755
-0.1% -$323K 0.01% 877
2024
Q1
$318M Buy
11,489,517
+1,058,507
+10% +$23.5M 0.02% 602
2023
Q4
$201M Sell
10,431,010
-1,048,199
-9% -$19M 0.02% 747
2023
Q3
$186M Buy
11,479,209
+1,103,275
+11% +$19.6M 0.02% 730
2023
Q2
$198M Sell
10,375,934
-1,065,891
-9% -$19M 0.02% 723
2023
Q1
$166M Buy
11,441,825
+6,680
+0.1% +$120K 0.02% 779
2022
Q4
$223M Sell
11,435,145
-1,989
-0% -$38.8K 0.02% 639
2022
Q3
$276M Buy
11,437,134
+20,921
+0.2% +$645K 0.03% 552
2022
Q2
$359M Buy
11,416,213
+1,453,854
+15% +$52.7M 0.04% 491
2022
Q1
$439M Buy
9,962,359
+6,565,377
+193% +$282M 0.04% 481
2021
Q4
$148M Buy
3,396,982
+1,915,049
+129% +$75.1M 0.01% 918
2021
Q3
$46.4M Sell
1,481,933
-610,512
-29% -$24M ﹤0.01% 1444
2021
Q2
$88.6M Sell
2,092,445
-528,334
-20% -$20.6M 0.01% 1170
2021
Q1
$98.5M Sell
2,620,779
-611,594
-19% -$19.1M 0.01% 1073
2020
Q4
$87.4M Buy
3,232,373
+3,232,364
+35,915,156% +$83.1M 0.01% 1089
2020
Q3
$0 Buy
9
+6
+200% +$88 ﹤0.01% 3904
2020
Q2
$0 Buy
3
+2
+200% +$15 ﹤0.01% 4001
2020
Q1
$0 Sell
1
-605
-100% -$3.65K ﹤0.01% 4074
2019
Q4
$3K Buy
606
+3
+0.5% +$19 ﹤0.01% 3509
2019
Q3
$3K Sell
603
-917
-60% -$4.11K ﹤0.01% 3502
2019
Q2
$5K Buy
1,520
+1,513
+21,614% +$5.16K ﹤0.01% 3380
2019
Q1
$0 Sell
7
-4,775
-100% -$30.2K ﹤0.01% 4033
2018
Q4
$30K Buy
4,782
+4,779
+159,300% +$49.6K ﹤0.01% 2824
2018
Q3
$0 Buy
+3
New +$51 ﹤0.01% 3715
2018
Q1
Sell
-1,414,300
Closed -$26.7M 2719
2017
Q4
$26.7M Buy
+1,414,300
New +$31.4M ﹤0.01% 1590
2017
Q3
Sell
-2,500,000
Closed -$80.5M 2638
2017
Q2
$80.5M Hold
2,500,000
0.01% 1082
2017
Q1
$86.5M Hold
2,500,000
0.01% 1046
2016
Q4
$88.2M Hold
2,500,000
0.01% 1055
2016
Q3
$86.8M Hold
2,500,000
0.01% 1047
2016
Q2
$93.5M Hold
2,500,000
0.01% 1009
2016
Q1
$101M Sell
2,500,000
-700,000
-22% -$26.1M 0.01% 958
2015
Q4
$115M Hold
3,200,000
0.02% 906
2015
Q3
$102M Hold
3,200,000
0.01% 947
2015
Q2
$109M Hold
3,200,000
0.01% 1000
2015
Q1
$108M Hold
3,200,000
0.01% 989
2014
Q4
$112M Hold
3,200,000
0.01% 957
2014
Q3
$105M Hold
3,200,000
0.01% 947
2014
Q2
$109M Sell
3,200,000
-200,000
-6% -$6.85M 0.01% 958
2014
Q1
$119M Hold
3,400,000
0.02% 885
2013
Q4
$124M Hold
3,400,000
0.02% 853
2013
Q3
$118M Hold
3,400,000
0.02% 871
2013
Q2
$115M Buy
+3,400,000
New +$113M 0.02% 849

Other funds holding ACH

Fidelity Investments's ACH Position: Q2 2026 in Review

Fidelity Investments increased its Accendra Health (ACH) stake by 5.8% in Q2 2026, buying an estimated $4.39K and bringing the position to 25,912 shares worth $88.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4030.

Fidelity Investments first reported a position in ACH in Q2 2013 and has held it in 50 quarters since. The position peaked at $439M in Q1 2022. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • Fidelity Investments held 25,912 shares of Accendra Health worth $88.6K as of Q2 2026.
  • Fidelity Investments bought 1,413 Accendra Health shares in Q2 2026, an estimated $4.39K.
  • Accendra Health made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #4030 holding.
  • Fidelity Investments first reported a position in Accendra Health in Q2 2013 and has held it in 50 quarters since.
  • Fidelity Investments's Accendra Health position peaked at $439M in Q1 2022.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.